Versatrol Controlled Release Softgels

Source: Patheon Inc.

Innovative controlled release delivery system employs unique matrix formulations for both lipophilic and hydrophilic compounds. Compatible with proprietary EnteriCare® enteric softgels technology enabling delivery of the active ingredient directly to the small intestine. 

Key Dosage Form Characteristics

  • Controlled release softgel for both lipophilic and hydrophilic compounds
  • Customized and more predictable release profile achieved by tailoring the formulation variables 
  • Unique matrix formulations 
  • Ability to customize release profiles 
  • Compatible with proprietary EnteriCare® enteric softgels technology 
  • Patent pending technology

For full access to this content, please Register or Sign In.

Access Content Versatrol Controlled Release Softgels